
- Pharmaceutical Technology, March 2022 Issue
- Volume 46
- Issue 3
- Pages: 12
Relative Humidity Controller
Linkam Scientific’s RHGen Relative Humidity (RH) controller allows for precise control of sample humidity without need for an external dry air supply.
Linkam Scientific’s RHGen Relative Humidity (RH) controller offers humidity control between 3% and 95% RH at temperatures from ambient to 85 °C. Relative to past models, it has an upgraded RH sensor and improved connectors, providing environmental control to a variety of Linkam temperature control stages and third-party chambers.
The RHGen allows for precise control of the humidity around a sample without need for an external dry air supply. Accurate humidity control is maintained through close placement of the feedback sensor to the sample block. Magnetic connectors for the bottle enable easy water changing and refilling for users.
The device can be combined with the Inert Gas Regulator, which acts as a regulated pressure interface between the RHGen and an external gas supply to allow inert gasses into the chamber. This allows the RHGen to replicate unique environmental conditions. It can also be used in conjunction with light microscopy, Raman, Fourier transform infrared, and X-ray for further sample characterization.
Articles in this issue
almost 4 years ago
The Shape of Dosage Formsalmost 4 years ago
Successfully Accelerating Formulation Strategiesalmost 4 years ago
Process Performance as a Means of Quality Managementalmost 4 years ago
The State of Phage Therapyalmost 4 years ago
Troubleshooting Using Predictive Maintenancealmost 4 years ago
A New Route to Pharma GDP Compliance and Standardizationalmost 4 years ago
Empowering Protein Characterizationalmost 4 years ago
Cold Comfort for Bio/Pharmaalmost 4 years ago
Selecting and Optimizing the Right Manufacturing Partneralmost 4 years ago
Standing in SolidarityNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




